MedTrace Logo

Safety and Efficacy of Using MASTER to Perform Endoscopic Submucosal Dissection in Human

NCT01464918 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 7

Last updated 2011-11-04

No results posted yet for this study

Summary

This trial is to evaluate the safety and efficacy of using MASTER, a robotics enhanced endosurgical system to perform endoscopic submucosal dissection (ESD) of gastric/colon cancer in human.

Conditions

Interventions

DEVICE

Endoscopic submucosal dissection (ESD) using device, MASTER

Performing endoscopic submucosal dissection (ESD)of the gastric/colon cancer using the device, MASTER

Sponsors & Collaborators

  • Prince of Wales Hospital, Shatin, Hong Kong

    collaborator OTHER

  • Apollo Gleneagles Hospitals, Kolkata

    collaborator OTHER

  • National University Hospital, Singapore

    lead OTHER

Principal Investigators

  • Khek Yu Ho, MBBS; MD · National University Hospital, Singapore

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
21 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-11-30
Primary Completion
2012-12-31
Completion
2012-12-31

Countries

  • China
  • India
  • Singapore

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01464918 on ClinicalTrials.gov